|
1
|
Huang X, Qiu L, Huang S, Liang D, Chen X. Transcription Factor FOXD3 Regulates ELAV1/TLR4 Axis in Antiphospholipid Syndrome to Mediate Proliferation and Migration of Trophoblasts. Mol Reprod Dev 2025; 92:e70021. [PMID: 40165384 DOI: 10.1002/mrd.70021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/11/2024] [Revised: 02/02/2025] [Accepted: 03/05/2025] [Indexed: 04/02/2025]
Abstract
This study focused on exploring the mechanism of transcription factor FOXD3 promoting the proliferation, migration, and invasion of trophoblast through ELAV1/TLR4 axis. The placenta villi from pregnancy patients with antiphospholipid syndrome (APS) and pregnancy controls were collected, along with the HTR-8/SVneo cell lines were obtained to detect the FOXD3, ELAV1, and TLR4 expressions using qRT-PCR and western blot. The interaction of ELAV1 with TLR4 mRNA was verified using RNA immunoprecipitation. The binding of FOXD3 with ELAV1 was detected using Chromatin Immunoprecipitation and dual luciferase reporter gene assay. After cell transfection, the cell proliferation, cell cycle distribution, invasion, and migration of the HTR-8/SVneo cell line were also measured. FOXD3, ELAV1, and TLR4 were elevated in the placenta villi of APS patients. TLR4 knockdown can promote the proliferation, invasion, and migration ability of HTR-8/SVneo cells. ELAV1 can bind TLR4 mRNA and increase its stability. TLR4 overexpression can inhibit the promotive effect of ELAV1 knockdown on HTR-8/SVneo cell biological functions. FOXD3 can bind the ELAV1 promoter and increase its transcription level to mediate HTR-8/SVneo cell biological functions. FOXD3 can bind and increase ELAV1 expression to stabilize TLR4 mRNA level, thereby increasing TLR4 expression and inhibiting the proliferation, invasion, and migration ability of trophoblast.
Collapse
Affiliation(s)
- Xiaolan Huang
- Department of Reproductive Medicine, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, P.R. China
| | - Lingling Qiu
- Department of Reproductive Medicine, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, P.R. China
| | - Suzhen Huang
- Department of Reproductive Medicine, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, P.R. China
| | - Danhong Liang
- Department of Reproductive Medicine, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, P.R. China
| | - Xiaoqing Chen
- Department of Rheumatology and Immunology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, P.R. China
| |
Collapse
|
|
2
|
Xue M, March L. Endothelial Protein C Receptor: A Multifunctional Mediator in the Pathophysiology of Rheumatoid Arthritis. Cells 2025; 14:485. [PMID: 40214439 PMCID: PMC11987911 DOI: 10.3390/cells14070485] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/02/2025] [Revised: 03/11/2025] [Accepted: 03/19/2025] [Indexed: 04/14/2025] Open
Abstract
The endothelial protein C receptor (EPCR) is gaining recognition for its diverse functions that extend beyond its traditional role in the protein C anticoagulant pathway. This comprehensive review examines how EPCR contributes to the pathophysiology of rheumatoid arthritis (RA), an autoimmune disorder characterized by persistent inflammation and joint destruction. We explore how EPCR influences inflammatory responses and the coagulation cascade, affects endothelial function and vascular integrity, and regulates the characteristics of synovial fibroblasts in the context of RA. Furthermore, the review highlights the mechanisms by which EPCR affects disease progression, its potential use as a biomarker for disease activity, and the therapeutic implications of targeting EPCR in the treatment of RA. By synthesizing current research findings, this review aims to provide a detailed understanding of EPCR's role in RA, offering insights into innovative diagnostic and therapeutic strategies that could improve patient outcomes.
Collapse
Affiliation(s)
- Meilang Xue
- Sutton Arthritis Research Laboratory, Sydney Musculoskeletal Health, Kolling Institute, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2065, Australia
- The Australian Arthritis and Autoimmune Biobank Collaborative (A3BC), Sydney Musculoskeletal Health, Kolling Institute, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2065, Australia;
| | - Lyn March
- The Australian Arthritis and Autoimmune Biobank Collaborative (A3BC), Sydney Musculoskeletal Health, Kolling Institute, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2065, Australia;
- Department of Rheumatology, Royal North Shore Hospital, Syndey, NSW 2065, Australia
| |
Collapse
|
|
3
|
Bardan CR, Ioniță I, Iordache M, Călămar-Popovici D, Todorescu V, Popescu R, Bernad BC, Bardan R, Bernad ES. Epigenetic Biomarkers in Thrombophilia-Related Pregnancy Complications: Mechanisms, Diagnostic Potential, and Therapeutic Implications: A Narrative Review. Int J Mol Sci 2024; 25:13634. [PMID: 39769397 PMCID: PMC11728153 DOI: 10.3390/ijms252413634] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/13/2024] [Revised: 12/16/2024] [Accepted: 12/18/2024] [Indexed: 01/14/2025] Open
Abstract
Pregnancy complications associated with thrombophilia represent significant risks for maternal and fetal health, leading to adverse outcomes such as pre-eclampsia, recurrent pregnancy loss, and intra-uterine growth restriction (IUGR). They are caused by disruptions in key physiological processes, including the coagulation cascade, trophoblast invasion, angiogenesis, and immune control. Recent advancements in epigenetics have revealed that non-coding RNAs, especially microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and extracellular vesicles (EVs) carrying these RNAs, play crucial roles in the regulation of these biological processes. This review aims to identify the epigenetic biomarkers that are the best candidates for evaluating thrombophilia-related pregnancy complications and for assessing the efficacy of anticoagulant and antiaggregant therapies. We emphasize their potential integration into personalized treatment plans, aiming to improve the risk assessment and therapy strategies for thrombophilic pregnancies. Future research should focus on validating these epigenetic biomarkers and establishing standardized protocols to enable their integration into clinical practice, paving the way for a precision medicine approach in obstetric care.
Collapse
Affiliation(s)
- Claudia Ramona Bardan
- Doctoral School, Faculty of Medicine, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timisoara, Romania; (C.R.B.); (B.C.B.)
- Clinic of Hematology, Municipal Clinical Emergency Hospital, 300254 Timisoara, Romania; (I.I.); (M.I.); (D.C.-P.); (V.T.)
| | - Ioana Ioniță
- Clinic of Hematology, Municipal Clinical Emergency Hospital, 300254 Timisoara, Romania; (I.I.); (M.I.); (D.C.-P.); (V.T.)
- Department of Hematology, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timisoara, Romania
| | - Maria Iordache
- Clinic of Hematology, Municipal Clinical Emergency Hospital, 300254 Timisoara, Romania; (I.I.); (M.I.); (D.C.-P.); (V.T.)
- Department of Hematology, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timisoara, Romania
| | - Despina Călămar-Popovici
- Clinic of Hematology, Municipal Clinical Emergency Hospital, 300254 Timisoara, Romania; (I.I.); (M.I.); (D.C.-P.); (V.T.)
- Department of Hematology, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timisoara, Romania
| | - Violeta Todorescu
- Clinic of Hematology, Municipal Clinical Emergency Hospital, 300254 Timisoara, Romania; (I.I.); (M.I.); (D.C.-P.); (V.T.)
- Department of Hematology, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timisoara, Romania
| | - Roxana Popescu
- Division of Cell and Molecular Biology, Department of Microscopic Morphology, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timisoara, Romania;
| | - Brenda Cristiana Bernad
- Doctoral School, Faculty of Medicine, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timisoara, Romania; (C.R.B.); (B.C.B.)
- Center for Neuropsychology and Behavioral Medicine, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timisoara, Romania
| | - Răzvan Bardan
- Department of Urology, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timisoara, Romania
- Clinic of Urology, “Pius Brînzeu” County Clinical Emergency Hospital, 300723 Timisoara, Romania
| | - Elena Silvia Bernad
- Department of Obstetrics and Gynecology, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timisoara, Romania;
- Clinic of Obstetrics and Gynecology, “Pius Brînzeu” County Clinical Emergency Hospital, 300723 Timisoara, Romania
- Center for Laparoscopy, Laparoscopic Surgery and In Vitro Fertilization, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timisoara, Romania
| |
Collapse
|
|
4
|
Fierro JJ, Prins JR, Henning S, Bootsma H, Westra J, de Leeuw K. Endometrial immune profiling as a new tool for preconceptional assessment in patients with systemic autoimmune diseases. Front Immunol 2024; 14:1334231. [PMID: 38250081 PMCID: PMC10797870 DOI: 10.3389/fimmu.2023.1334231] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/06/2023] [Accepted: 12/15/2023] [Indexed: 01/23/2024] Open
Affiliation(s)
- Juan J Fierro
- Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands
- Grupo Reproducción, Departamento de Microbiología y Parasitología, Universidad de Antioquia UdeA, Medellín, Colombia
| | - Jelmer R Prins
- Department of Obstetrics and Gynecology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands
| | - Svenja Henning
- Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands
| | - Hendrika Bootsma
- Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands
| | - Johanna Westra
- Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands
| | - Karina de Leeuw
- Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands
| |
Collapse
|